Elizabeth Mackie, PA
Physician Assistant · Bellaire, TXNPI 1679992234
Payments from drug & device makers
Across 928 payments — averaging $133.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$80K
- AbbVie$31K
- Dermavant Sciences, Inc.$4K
- UCB, Inc.$1K
- Johnson & Johnson$1K
- Arcutis Biotherapeutics, Inc.$912
- plus $6K from 24 others
What the payments were for
- Consulting fees$5,8805%
- Speaking & faculty fees$90,09973%
- Travel & lodging$9,1327%
- Food & beverage$18,48015%
- Education$4100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 227 | $80,267 |
| AbbVie(2 entities) | 297 | $30,676 |
| Dermavant Sciences, Inc. | 47 | $3,537 |
| UCB, Inc. | 13 | $1,493 |
| Johnson & Johnson | 53 | $1,195 |
| Arcutis Biotherapeutics, Inc. | 36 | $912 |
| Sanofi | 28 | $765 |
| Sun Pharmaceutical Industries Inc. | 20 | $727 |
| Regeneron Healthcare Solutions, Inc. | 30 | $708 |
| E.r. Squibb & Sons, L.L.C. | 13 | $630 |
| Amgen | 24 | $490 |
| Pfizer | 34 | $460 |
| Mayne Pharma Commercial LLC | 24 | $282 |
| Incyte Corporation | 5 | $274 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $262 |
| Galderma Laboratories, L.p. | 9 | $223 |
| Almirall LLC | 10 | $203 |
| Organon | 15 | $156 |
| LEO Pharma Inc. | 5 | $128 |
| Journey Medical Corporation | 1 | $125 |
| Novartis | 7 | $110 |
| Boehringer Ingelheim | 4 | $81 |
| Biofrontera Inc. | 4 | $77 |
| Organogenesis Inc. | 3 | $67 |
| Eli Lilly | 2 | $55 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $36 |
| Genentech USA, Inc. | 1 | $20 |
| Sandoz | 1 | $19 |
| Dermira, Inc. | 1 | $12 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$124,001 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $86,599 |
| Doxycycline Hyclate | 54 | $2,418 |
| Ketoconazole | 137 | $1,802 |
| Clobetasol Propionate | 23 | $1,434 |
| Triamcinolone Acetonide | 99 | $1,148 |
| Metronidazole | 12 | $936 |
| Fluocinonide | 17 | $476 |
| Finasteride | 34 | $431 |
| Ammonium Lactate | 20 | $367 |
| Fluconazole | 22 | $330 |
| Hydrocortisone | 64 | $299 |
| Mupirocin | 40 | $294 |
| Hydroxychloroquine Sulfate | 14 | $272 |
| ValacyclovirValacyclovir Hcl | 11 | $250 |
| Minoxidil | 24 | $175 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Bellaire
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.